Dominari (NASDAQ:DOMH) versus Carlyle Secured Lending (NASDAQ:CGBD) Critical Survey

Carlyle Secured Lending (NASDAQ:CGBDGet Free Report) and Dominari (NASDAQ:DOMHGet Free Report) are both small-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, risk, institutional ownership, valuation, dividends and profitability.

Analyst Ratings

This is a breakdown of recent recommendations for Carlyle Secured Lending and Dominari, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Carlyle Secured Lending 0 4 3 0 2.43
Dominari 1 0 0 0 1.00

Carlyle Secured Lending currently has a consensus target price of $12.50, indicating a potential upside of 9.94%. Given Carlyle Secured Lending’s stronger consensus rating and higher probable upside, equities analysts clearly believe Carlyle Secured Lending is more favorable than Dominari.

Profitability

This table compares Carlyle Secured Lending and Dominari’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Carlyle Secured Lending 14.26% 8.85% 3.90%
Dominari -51.61% -235.37% -163.66%

Earnings and Valuation

This table compares Carlyle Secured Lending and Dominari”s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Carlyle Secured Lending $255.57 million 3.06 $69.97 million $0.51 22.29
Dominari $123.10 million 0.43 -$22.43 million ($5.39) -0.40

Carlyle Secured Lending has higher revenue and earnings than Dominari. Dominari is trading at a lower price-to-earnings ratio than Carlyle Secured Lending, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Carlyle Secured Lending has a beta of 0.64, meaning that its stock price is 36% less volatile than the S&P 500. Comparatively, Dominari has a beta of 0.87, meaning that its stock price is 13% less volatile than the S&P 500.

Insider and Institutional Ownership

24.5% of Carlyle Secured Lending shares are owned by institutional investors. Comparatively, 42.5% of Dominari shares are owned by institutional investors. 0.3% of Carlyle Secured Lending shares are owned by company insiders. Comparatively, 55.3% of Dominari shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Carlyle Secured Lending beats Dominari on 11 of the 14 factors compared between the two stocks.

About Carlyle Secured Lending

(Get Free Report)

Carlyle Secured Lending, Inc. is business development company specializing in first lien debt, senior secured loans, second lien senior secured loan unsecured debt, mezzanine debt and investments in equities. It specializes in directly investing. It specializes in middle market. It targets healthcare and pharmaceutical, aerospace and defense, high tech industries, business services, software, beverage food and tobacco, hotel gamming and leisure, banking finance insurance and in real estate sector. The fund seeks to invest across United States of America, Luxembourg, Cayman Islands, Cyprus, and United Kingdom. It invests in companies with EBITDA between $25 million and $100 million.

About Dominari

(Get Free Report)

Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as AIkido Pharma Inc. and changed its name to Dominari Holdings Inc. in December 2022. Dominari Holdings Inc. was founded in 1967 and is headquartered in New York, New York.

Receive News & Ratings for Carlyle Secured Lending Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carlyle Secured Lending and related companies with MarketBeat.com's FREE daily email newsletter.